Janssen-Cilag International NV (JNJ) Release: New and Long-Term Use Results for Canagliflozin to be Presented at European Association for the Study of Diabetes Annual Meeting
9/18/2013 10:09:49 AM
BEERSE, Belgium--(BUSINESS WIRE)--Janssen-Cilag International NV (Janssen) announced today that 12 presentations on canagliflozin will be made at the upcoming annual meeting of the European Association for the Study of Diabetes (EASD), from September 24-27 in Barcelona, Spain.
Help employers find you! Check out all the jobs and post your resume.